Suppr超能文献

膀胱内卡介苗对膀胱扁平原位癌的长期影响。

Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.

作者信息

Herr H W, Pinsky C M, Whitmore W F, Sogani P C, Oettgen H F, Melamed M R

出版信息

J Urol. 1986 Feb;135(2):265-7. doi: 10.1016/s0022-5347(17)45604-7.

Abstract

Intravesical bacillus Calmette-Guerin is effective therapy for multifocal carcinoma in situ of the bladder. The duration of this favorable response and its effect on disease progression are the subject of this report. Between March 1978 and July 1981, 47 patients with diffuse, often symptomatic, carcinoma in situ were treated with intravesical bacillus Calmette-Guerin and followed every 3 to 4 months with cystoendoscopy, biopsy and urine cytology for 3 to 6 years. All patients had had prior or concurrent superficial papillary tumors controlled initially by transurethral resection and fulguration 2 to 3 weeks before bacillus Calmette-Guerin treatment. Of the 47 patients 23 were entered into a randomized study, and received intravesical and percutaneous bacillus Calmette-Guerin. Another 24 patients with carcinoma in situ were treated with intravesical bacillus Calmette-Guerin alone. Bacillus Calmette-Guerin (Pasteur strain) was given intravesically (120 mg. in 50 ml. saline) weekly for 6 weeks. Of the 47 patients 32 (68 per cent) are free of disease (negative urine cytology, cystoendoscopy and biopsy): 15 (65 per cent) after combined bacillus Calmette-Guerin for a median duration of 51 months (range 37 to 75 months) and 17 (71 per cent) after intravesical bacillus Calmette-Guerin alone for a median of 45 months (range 36 to 53 months). Of the 23 patients in the randomized study 4 (17 per cent) have required cystectomy for local progression of disease compared to 17 of 26 controls (65 per cent) who were randomized to transurethral resection and fulguration alone. Cystectomy was performed 3 to 27 months after bacillus Calmette-Guerin treatment and in 3 patients tumor was localized to the prostate gland (no tumor found within the bladder). These data indicate that intravesical bacillus Calmette-Guerin is capable of producing long-term remissions of carcinoma in situ in high risk patients and may prevent or delay progression of disease necessitating cystectomy.

摘要

膀胱内灌注卡介苗是治疗膀胱多灶性原位癌的有效方法。这种良好反应的持续时间及其对疾病进展的影响是本报告的主题。1978年3月至1981年7月期间,47例弥漫性、常有症状的原位癌患者接受了膀胱内卡介苗治疗,并每3至4个月进行一次膀胱镜检查、活检和尿液细胞学检查,随访3至6年。所有患者在卡介苗治疗前2至3周曾有过经尿道切除和电灼术初步控制的既往或同时存在的浅表乳头状肿瘤。47例患者中,23例进入随机研究,接受膀胱内和经皮卡介苗治疗。另外24例原位癌患者仅接受膀胱内卡介苗治疗。卡介苗(巴斯德菌株)以120毫克溶于50毫升盐水中,每周膀胱内灌注1次,共6周。47例患者中,32例(68%)无疾病(尿液细胞学、膀胱镜检查和活检均为阴性):联合卡介苗治疗后15例(65%),中位持续时间为51个月(范围37至75个月);仅膀胱内卡介苗治疗后17例(71%),中位时间为45个月(范围36至53个月)。随机研究的23例患者中,4例(17%)因疾病局部进展需要行膀胱切除术,而随机接受单纯经尿道切除和电灼术的26例对照组患者中有17例(65%)需要行膀胱切除术。膀胱切除术在卡介苗治疗后3至27个月进行,3例患者肿瘤局限于前列腺(膀胱内未发现肿瘤)。这些数据表明,膀胱内卡介苗能够使高危患者的原位癌获得长期缓解,并可能预防或延迟需要行膀胱切除术的疾病进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验